EyeIC develops MatchedFlicker, an imaging system for monitoring the advent and progression of retinal disease and glaucoma through change detection in time-series images. MatchedFlicker was recently approved for patient use by the Food and Drug Administration and the technology has broader applications throughout medicine. The company was founded around patented technology developed by Dr. Jeffrey Berger at the University of Pennsylvania’s School of Medicine and is based in West Conshohocken, Pennsylvania. Leadership includes President and CEO Philip Heifetz and Technology Director Steve Bakanov, MS, Ph.D. Financially, EyeIC received a $150K follow-on investment from Ben Franklin Technology Partners of Southeastern Pennsylvania. Ben Franklin had previously invested $575K, and other backers include Launch Capital and MentorTech Ventures.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2012